BFM
IDXX icon

Boothbay Fund Management’s Idexx Laboratories IDXX Stock Holding History

Boothbay Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-413
Closed -$279K – 2251
2025
Q4 		$279K Buy
+413
New +$281K ﹤0.01% 1478
2025
Q3 		– Sell
-506
Closed -$271K – 2001
2025
Q2 		$271K Buy
+506
New +$242K 0.01% 1144
2024
Q4 		– Sell
-607
Closed -$307K – 1692
2024
Q3 		$307K Sell
607
-122
-17% -$59.3K 0.01% 1224
2024
Q2 		$355K Buy
729
+244
+50% +$122K 0.01% 1103
2024
Q1 		$262K Buy
+485
New +$265K 0.01% 1244
2018
Q2 		– Sell
-2,318
Closed -$444K – 811
2018
Q1 		$444K Buy
2,318
+818
+55% +$151K 0.05% 355
2017
Q4 		$235K Sell
1,500
-302
-17% -$47.5K 0.03% 527
2017
Q3 		$280K Sell
1,802
-2,197
-55% -$347K 0.05% 400
2017
Q2 		$646K Buy
+3,999
New +$649K 0.13% 169
2016
Q4 		– Sell
-2,137
Closed -$241K – 842
2016
Q3 		$241K Buy
+2,137
New +$225K 0.05% 472

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's IDXX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 413 shares — an estimated $279K sold.

Boothbay Fund Management first reported a position in IDXX in Q3 2016 and held it in 10 quarters. The position peaked at $646K in Q2 2017. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 413 Idexx Laboratories shares in Q1 2026, an estimated $279K.
  • Boothbay Fund Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 10 quarters.
  • Boothbay Fund Management's Idexx Laboratories position peaked at $646K in Q2 2017.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.